PlainRecalls
FDA Drug Moderate Class II Terminated

Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 30-count bottle, Rx only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC., 20 Waterview Blvd., Parsippany, NJ 07054, USA; NDC 64679-735-09, UPC 3 64679 73509 1.

Reported: May 14, 2014 Initiated: April 1, 2014 #D-1300-2014

Product Description

Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 30-count bottle, Rx only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC., 20 Waterview Blvd., Parsippany, NJ 07054, USA; NDC 64679-735-09, UPC 3 64679 73509 1.

Reason for Recall

Failed Dissolution Specifications: failure of dissolution test observed at nine month time point.

Details

Recalling Firm
Wockhardt Usa Inc.
Units Affected
109,744 bottles
Distribution
Nationwide
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 30-count bottle, Rx only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC., 20 Waterview Blvd., Parsippany, NJ 07054, USA; NDC 64679-735-09, UPC 3 64679 73509 1.. Recalled by Wockhardt Usa Inc.. Units affected: 109,744 bottles.
Why was this product recalled?
Failed Dissolution Specifications: failure of dissolution test observed at nine month time point.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 14, 2014. Severity: Moderate. Recall number: D-1300-2014.